ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 130 filers reported holding ALLAKOS INC in Q2 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,405 | -47.9% | 1,500 | 0.0% | 0.00% | – |
| Q2 2023 | $6,540 | -2.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2023 | $6,675 | +233.8% | 1,500 | +614.3% | 0.00% | – |
| Q4 2021 | $2,000 | -90.9% | 210 | 0.0% | 0.00% | – |
| Q3 2021 | $22,000 | +22.2% | 210 | 0.0% | 0.00% | – |
| Q2 2021 | $18,000 | -100.0% | 210 | -50.0% | 0.00% | – |
| Q1 2021 | $48,208,000 | +166134.5% | 420 | +100.0% | 0.00% | -100.0% |
| Q4 2020 | $29,000 | +70.6% | 210 | 0.0% | 0.00% | – |
| Q3 2020 | $17,000 | -22.7% | 210 | -32.3% | 0.00% | -100.0% |
| Q2 2020 | $22,000 | +450.0% | 310 | +210.0% | 0.00% | – |
| Q1 2020 | $4,000 | -55.6% | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | -18.2% | 100 | -33.3% | 0.00% | – |
| Q3 2019 | $11,000 | +83.3% | 150 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | -14.3% | 150 | 0.0% | 0.00% | – |
| Q3 2018 | $7,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 4,887,932 | $561,037,000 | 86.41% |
| Fairmount Funds Management LLC | 147,662 | $16,949,000 | 7.14% |
| NEA Management Company, LLC | 2,164,704 | $248,465,000 | 5.58% |
| Redmile Group, LLC | 2,419,418 | $277,701,000 | 3.91% |
| Samsara BioCapital, LLC | 146,259 | $16,788,000 | 3.10% |
| Samsara BioCapital, LLC | 83,000 | $9,527,000 | 1.76% |
| Rock Springs Capital Management LP | 305,706 | $35,089,000 | 0.77% |
| Tekla Capital Management LLC | 163,645 | $18,783,000 | 0.65% |
| Legal Advantage Investments, Inc. | 7,000 | $803,000 | 0.60% |
| Eventide Asset Management | 317,000 | $36,385,000 | 0.54% |